CHEKMICRO

Check-Cap Ltd.

HealthcareMedical - Diagnostics & Research
$1.86
$0.00(-10.58%)
52W$0.59
$3.92
Updated Jun 30, 02:00 AM
RSI49
RS Rating54/99
Beta1.47
Volatility110%
F-Score2/9
Mkt Cap$11M
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Check-Cap Ltd. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 54), indicating performance broadly in line with the market. Earnings contraction of 156% provides fundamental context to the price action. Investors should exercise caution due to high volatility (110% annualized), which requires wider risk management.

Relative Strength
54
out of 99
Average
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
1.47
vs S&P 500
ABOVE MKT
52W Position
38%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1.65
50 SMA > 100 SMA$1.56
100 SMA > 150 SMA$1.29
150 SMA > 200 SMA$1.17

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.81+2.96%ABOVE
50 SMA$1.65+12.48%ABOVE
100 SMA$1.56+19.51%ABOVE
150 SMA$1.29+44.30%ABOVE
200 SMA$1.17+59.57%ABOVE

Price Performance

1D-10.6%
1W
1M
3M+0.0%
6M+10.7%
YTD+8.5%
1Y+141.2%
3Y-11.0%
52-Week Trading Range38% from low
$1.86
52W Low$0.59
52W High$3.92

Technical Indicators

RSI (14)NEUTRAL
48.6
305070
Setup ScoreCOOL
1/10
Base depth: 145.7%

Risk Profile

Beta
1.47
52W Vol
110%
ATR
$0.38
Max DD (1Y)
-52%

Volume Analysis

Today
39.4K
50D Avg
39.4K
Vol Ratio
1.00x
Liquidity
ILLIQUID

Earnings Momentum

Q1'24+22%
$-0.54
Q2'24+54%
$-0.54
Q3'24-266%
$-1.61
Q4'24-156%
$-1.61
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:+25.54%
5 Years:
3 Years:
TTM:-46.26%

Stock Price CAGR

10 Years:-40.65%
5 Years:-42.73%
3 Years:-11.02%
1 Year:+141.18%

Return on Equity

10Y Avg:-111.3%
5Y Avg:-99.1%
3Y Avg:-107.3%
Last Year:-226.2%

Key Metrics

Market Cap$11M
Gross Margin
Net Margin
Piotroski F-Score2/9

Frequently Asked Questions

Is CHEK in an uptrend right now?

CHEK has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, CHEK is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is CHEK overbought or oversold?

CHEK's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.

Is CHEK outperforming the market?

CHEK has a Relative Strength (RS) Rating of 54 out of 99. CHEK is performing about average compared to the market.

Where is CHEK in its 52-week range?

CHEK is trading at $1.86, which is 47% of its 52-week high ($3.92) and 38% above its 52-week low ($0.59).

How volatile is CHEK?

CHEK has a Beta of 1.47 and 52-week volatility of 110%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.